Key result
Overexpression of MnSOD protected against acute Adriamycin-induced mitochondrial injury, whereas iNOS deficiency potentiated it compared with nontransgenic mice.
Why the study?
Does overexpression of MnSOD or knockout of iNOS modify acute Adriamycin-induced mitochondrial toxicity in mice?
Population
Genetically engineered B6C3 mice (overexpressing manganese superoxide dismutase [TgM], inducible nitric…
Comparison
Adriamycin 20 mg/kg vs Nontransgenic mice treated with Adriamycin
Design
Preclinical
Follow-up
24 hours
Authors
Loading...
Hypothesis-generating for MnSOD/iNOS modulation in anthracycline mitochondrial toxicity; human validation required before any clinical consideration.
Does overexpression of MnSOD or knockout of iNOS modify acute Adriamycin-induced mitochondrial toxicity in mice?
Overexpression of MnSOD protects against, while iNOS deficiency exacerbates, acute Adriamycin-induced mitochondrial injury in a murine model.
Chaiswing et al. (2005) studied Acute Adriamycin-induced cardiotoxicity. MnSOD overexpression and iNOS deficiency vs. Nontransgenic mice was evaluated on Mitochondrial injury, 4HNE protein adducts, and 3NT levels. Overexpression of MnSOD protected against acute Adriamycin-induced mitochondrial injury, whereas iNOS deficiency potentiated it compared with nontransgenic mice.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: